The lead researcher, from Texas A&M University, told Newsweek that slowing down with age doesn't have to be the norm.
One vial of blood could provide an important clue about what’s happening inside the brain. The FDA has cleared ELECSYS ...
The Food and Drug Administration (FDA) has granted approval for a new test for Alzheimer’s disease, marking the fourth time ...
The FDA approved Roche Diagnostics and Eli Lilly’s blood test to help doctors assess Alzheimer’s disease in people 55 and ...
Kennesaw State University researcher Vishnu Suppiramaniam is advancing understanding of brain health across the lifespan, ...
Dr. Ian Grant, behavioral neurologist at Northwestern Medicine’s Cognitive Neurology & Alzheimer’s Disease Center, joins Bob ...
The next episode in this series, 'Empowering Primary Care: Early Alzheimer's Detection and the Referral Pathway Challenge,' features the panelists advancing their conversation on Alzheimer's disease ...
Late-onset Alzheimer's disease (AD) is a progressive disorder characterized by cognitive decline and memory impairment, ...
The adult human brain has limited capacity to repair or regenerate neurons lost to Alzheimer's disease, the most common type of dementia. Existing treatments can slow disease progression but do not ...
Two University of Wyoming faculty members will further their research in understanding the microcircuit changes that occur in ...
In this episode titled, 'Alzheimer's Disease Prevalence and Prevention: Building the Case for Early Diagnosis,' Kavita Nair, PhD ...
When the causal mutation is known, the challenge shifts from identifying disease origins to defining its detectable beginning ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results